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INTRODUCTION 
 
            Pregnancy  is  a state  associated  with changes  in anatomy , 
physiology, biochemistry
1
. The characteristic of normal  pregnancy  is  
developing  well tolerated  allograft i.e  fetus, developed placenta 
,increase in circulating  steroids
2
. As a result   of this  changes  serial  
alteration in lipid profile, mainly increase in serum  triglycerides, 
cholesterol occurs in  pregnant women. 
Preeclampsia is specific
2,3,4
  to pregnancy, multi  system  
involvement
5,6
. It is   hypertensive  disorder includes   new onset  
hypertension  and  proteinuria after  20weeks of  gestation and resolves  
after  delivery
2,7
. 
Preeclampsia  is a common medical  complication  in pregnancy in 
developing  countries
3,8
. It is  one  of the   most  common  cause that lead 
to maternal and fetal  morbidity  and  mortality
5,6,9,10
. Incidence  of  
Preeclampsia  in world  is  3-5%
3
. In India  preeclampsia  complicates   5-
15% of pregnancies
11
. 
Eventhough etiopathogenesis  of preeclampsia  remain obscure  
and poorly  understood
13
, genetic  component  may play  a major  role
12
. 
It  includes   complex  pathophysiological  state  in which   regulatory  
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systems of  inflammation  and  endothelial  function  are  altered  beyond  
the normal  physiological  limits of pregnancy
14
. 
Endothelial  dysfunction  may be  due  to the changes in 
metabolism of  lipoproteins
8,10
. The  mechanism  that  lead to  endothelial  
dysfunction is not  well defined. The  spectrum  of  endothelial  changes 
are provoked  by  multiple  circulating  factors  including  altered  
lipoproteins .Endothelial  dysfunction explains  many of  symptoms   of 
preeclampsia  including   proteinuria
5,10
. 
Even  in normal  pregnancy   there is  increase  in  plasma  lipid  
seen, but  in normal  pregnancy  it  is  not  atherogenic, may be  
physiological, due   to hormonal control
5,8
. Whenever  this   mechanism  
of  adjusting  physiologic  hyperlipidemia is  altered  that  lead  to 
complications  in pregnancy
2,6,15,16
. So, In pregnancy  if  serum  lipid   
profiles  are  estimated  it  helps to identify  high risk  cases   prone  for 
preeclampsia. Even  before,  some  studies  evaluated   lipid  profile  in 
preeclampsia  and  relationship  between  lipid concentration( 
serumtriglycerides)  and severity of preeclampsia is  evaluated .In my  
study  I included  serum  cholesterol, LDL-C, HDL-C also with 
Triglycerides. 
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This  study   was  conducted  in the  Department  of Obstetrics with 
the help  of  Biochemistry  Department, Coimbatore during  the  period of  
November  2012  to October 2013. 
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AIMS & OBJECTIVES 
AIM 
1) To compare the serum lipid parameters (triglycerides, total 
cholesterol, LDL, HDL) of normal pregnant women with 
gestational hypertension and preeclampsia. 
OBJECTIVES 
1. To measure serum lipid profile in gestational hypertension, 
preeclampsia and normal pregnant women. 
2. To compare serum lipid profile levels in three groups. 
3. To know the role of altered lipid profile in the  pathophysiology 
of preeclampsia. 
4. To establish the relationship between serum lipid profile and 
preeclampsia 
5. To correlate  the  lipid  profile   levels  with the severity of 
preeclampsia. 
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REVIEW OF LITERATURE 
 
             The major cause of  maternal , fetal  morbidity  and  mortality  is 
Preeclampsia. In pathogenesis of Preeclampsia, altered lipid metabolism   
seems important. 
DEFINITION
17 
        National High Blood Pressure Education Program (NHBPEP) 2000 
& ACOG (2002) defines   Gestational Hypertension  as, 
Systolic  pressure of  more  than equal to  140 mmHg, Diastolic  
pressure of more than  equal to  90mmHg after   20  weeks  of  
gestation,measured  4 to 6  hours apart  in a previously  normotensive   
women. 
  Severe   Hypertension  in pregnancy  is  defined  as, 
         a) Systolic  BP  greater  than  or equal  to  160 mmHg or 
         b) Diastolic  BP  greater than  or  equal  to   110 mmHg 
This  represents  a cut  off  level  of  BP  beyond  which cerebral  
autoregulation   stops   functioning ,  because  of  which  complications  
like   cerebral  hemorrhage   and hypertensive encephalopathy   may  
happen.  
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CLASSIFICATION OF HYPERTENSIVE DISORDERS IN  
PREGNANCY
17,18 
NHBPEP classifies as, 
1. Gestational   Hypertension 
2. Preeclampsia 
3. Eclampsia 
4. Super imposed Preeclampsia   on Chronic  Hypertension 
5. Chronic  Hypertension 
1.GESTATIONAL  HYPERTENSION 
Systolic  BP   of  greater  than or  equal to  140mmHg   or  
Diastolic  BP  of  greater  than  or equal to 90mmHg without   proteinuria 
and  other    imminent  symptoms  &signs  and  BP  returns  to normal  
before  12  weeks  post partum. 
2. PREECLAMPSIA 
   Systolic   BP  of greater  than or equal to 140mmHg  or Diastolic  
BP  of   greater  than or equal to 90mmHg  with  proteinuria  of  more  
than  300mg in 24 hours i.e  more  than  1+ in dipstick  test. 
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3.ECLAMPSIA 
Generalised   tonic  clonic  seizures  with  preeclampsia ,which  
cannot  be  contributed  by  other causes. 
4. SUPER IMPOSED PREECLAMPSIA ON CHRONIC   
HYPERTENSION 
It is  diagnosed by 
a) In  chronic  hypertension  patient   whenever   there  is  sudden   
increase  in blood pressure or,  proteinuria,  platelet  count. 
b) In   chronic hypertension  patient  whenever there new  onset  
of  proteinuria  of  more  than  300mg/24  hours.   
5. CHRONIC  HYPERTENSION 
Systolic   BP  of greater  than or   equal to 140mmHg  or Diastolic  
BP  of   greater  than or equal to 90mmHg  before    20  weeks   not  
including   gestational   trophoblastic disease, twin   .  Hypertension   
diagnosed  after  20  weeks of gestation  and persisting  after   12  weeks 
post partum. 
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ASSOCIATION OF DYSLIPIDEMIA AND PREECLAMPSIA 
 
 
 
 
 
 
 
 
 
 
 
   
      
 
  
  
  
 
DEVELOPMENT OF PREECLAMPSIA 
Figure-1.Role of altered lipid profile in the pathogenesis of preeclampsia 
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 The changes in lipid profile are due to changes in hepatic 
adipose tissue metabolism that alter circulating concentrations of TG,fatty 
acids, cholesterol and phospholipids and it is attributed to higher 
concentration of estrogen and state of relative insulin resistance
also characterised by increased 
lipoprotein lipase activity, leading to increase in circulating 
triglycerides
20
. Because of reduction in adipose tissue lipoprotein lipase 
activity, there is reduction in clearance of triglyceride rich lipoproteins
NORMAL PREGNANCY ASSOCIATED WITH 
HYPERTRIGLYCERIDEMIA
Figure-2:Cause of altered lipid profile in normal pregnancy
Estrogen,Insulin resistance
Increased hepatic lipase 
activity, decreased lipoprotein lipase 
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There was increasing evidence that in pathophysiologic mechanism 
of preeclampsia, lipid metabolism and circulating lipids play a major 
role
22
, because  lipid peroxides and oxidative imbalance  act as cytotoxic 
and lead to endothelial injury. Compared to normal pregnant women 
,women with preeclampsia have elevated lipid peroxides, and also 
severity of preeclampsia have a correlation with lipid peroxide levels
22
.In 
particular  levels of antioxidant in plasma and antioxidant activity  are 
low in preeclamptic women. Normally lipid peroxidation  was under 
control by variety of antioxidant mechanisms. But in women with 
preeclampsia, the balance of oxidant-antioxidant system was impaired. In 
women with preeclampsia, lipid peroxide production by placental tissue 
also elevated that lead to elevated concentration of lipid peroxides. Lipids 
interacts with oxygen free radical and forms lipid peroxide, which are 
unstable,highly reactive and damaging compounds
23
. They are toxic to 
the cells, enzymes by stimulating peroxidation reactions. In preeclampsia, 
the causal factor implicated is uncontrolled lipid peroxidation
24,25
. 
Elevated lipid peroxides act by modulating prostocyclin synthesis, 
alter important biochemical reactions in the cell and lead to endothelial 
cell dysfunction. Lipid peroxides alter the ratio between prostacyclin and 
thromboxane A2 by inhibiting prostacyclin synthase
25
. In preeclampsia 
,major clinical symptoms are due to this imbalance between prostacyclin 
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and thromboxane
23
. Lipid peroxides lead to impaired endothelial 
dependent relaxation by altering prostacyclin mechanism
25
.In 
preeclampsia , proteinuria is explained by endothelial cells damage by 
lipid peroxides in kidney. Oxidative stress causes endothelial 
dysfunction.In cell membrane unsaturated lipids and thiol containing 
proteins are susceptible to free radical attack
24
.There  is lot of evidence 
supports that in preeclampsia , there is increased free radical activity and 
free radicals will cause  lipid peroxidaion. Severity of preeclampsia  have 
positive correlation with high levels of oxidation products. During 
pregnancy, the increase in lipid peroxides and increase in preeclampsia 
were confined to lipoprotein bound factors.Free&LDL bound lipid 
peroxides exhibit cytotoxicity on endothelial cells
24
. In preeclamptic 
women , atherogenic lipid profile is seen,which is characterised by 
increase in triglycerides and small dense LDL. Increase in triglycerides 
predispose to preeclampsia by placental vasculopathy
27
. 
According to study conducted by Anne Catherine, he observed that 
higher concentration of phospholipid , lipid peroxides and TC in placental 
deciduas basalis tissue derived from women with Preeclampsia
27
. 
Atherosis  of spiral arteries in placental layers heighten the risk of 
placental disease. As Preeclampsia is multicausal disease,one of the 
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plausible etiological factor is ‘TRIGLYCERIDE RELATED 
VASCULOPATHY”
27
.  
In women with PIH, vascular changes in the placental bed is 
described  as “acute atherosis” due to lipid laden macrophages (foam 
cells ) in atherosclerotic plaque
14,17
. 
ACUTE ATHEROSIS: 
In preeclampsia distinct pathological lesion of decidual arterioles  
are termed as acute atherosis. The arteriopathy involves the spiral and 
myometrial arteries region,where  physiologic transformation changes 
were absent. Acute atherosis resembles atherosclerotic lesions of 
coronary arteries by showing endothelial disruption,platelet aggregation 
and accumulation of foam cells(lipid laden macrophages)
4,17
. In 
preeclampsia,acute atherosis of spiral areries  have two outstanding 
features. They are vessel wall necrosis and fatty change in intimal 
cells,which are analogous in systemic arterial disease. 
It is essential to explain why  some women in pregnancy develop 
preeclampsia, while others not , that is because of the existence maternal 
predisposing factors and  abnormal lipid metabolism could be one of  the  
factor. 
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         Alteration in lipid promote oxidative stress in preeclampsia.In 
pathogenesis of preeclampsia,insulin resistance  syndrome, 
(syndrome X-includes dyslipidemia, resistance to insulin mediated 
glucose uptake, obesity) have an important role
4
. 
         Multiple factors converge at particular point  of oxidative stress and 
result in endothelial dysfunction,clinical features of preeclampsia.Primary 
or secondary  maternal dyslipidemia lead to decrease of antioxidants 
results in preeclampsia
4
. 
Women with preeclampsia also predisposed to develop 
cardiovascular manifestation and coronary heart disease in later life
5
.In  
subsequent pregnancies also, They are prone to develop metabolic and 
hypertensive complications
17
. In particular, if preeclampsia diagnosed 
early in index pregnancy,the risk of recurrence is high.This was supported 
by Sibai and colleagues that nulliparous women diagnosed preeclampsia 
before 30 weeks have 40% recurrence risk in subsequent pregnancy
16
. 
Compared to recurrence in nulliparous women developing preeclampsia, 
the recurrence risk is high in multiparous women developing 
preeclampsia
17
. So, to prevent maternal and fetal morbidity and mortality, 
preeclampsia to be predicted as early as possible. 
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Saleh R et al noted inflammatory and atherosclerotic lesions in the 
placenta of preeclamptic women
28
 Presence of dyslipidemia in gestational 
hypertension and preeclampsia can aggravate the atherosclerotic plaque 
formation in uterine spiral arteries leading to narrowing of their lumen. 
This leads to significant reduction in the blood flow and placental 
ischemia thus setting up a vicious cycle of placental ischemia _ 
inflammation _ insulin resistance _ dyslipidemia _ atherosclerosis _ 
placental ischemia. 
                    
Figure-3:Dyslipidemia and preeclampsia 
STUDIES RELATED TO LIPID PROFILE &PREECLAMPSIA 
        A study conducted in primigravida about lipoprotein subfractions  
by Sattar N et al  also concluded that  high triglyceride concentration in 
preeclampsia is a main contributor to endothelial dysfunction. 
Placental 
ischaemia and 
preeclampsia
Inflammation
Insulin 
resistance
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A study conducted by Akhavan Setareh et al and Van den Elzen 
HJ et al  concluded that dyslipidemia in early pregnancy associated with  
preeclampsia development.Van den Elzen HJ et al , in his study 
demonstrated  a significant association of diastolic BP with serum total 
cholesterol in first trimester and from first to late second trimester the 
change in systolic and diastolic BP  showed linear relationship with 
serum total cholesterol and HDL-C
17
. 
          According to Akhavan Setareh et al  study,in  women with serum 
triglyceride concentration >175mg/dl the risk of preeclampsia was13 fold 
more than women with triglyceride concentration<100mg/dl
13
. 
Wakatsuki concluded in his study that in preeclampsia women  the 
plasma level of triglyceride and LDL were significantly higher than 
normals.According to JC Ray study,the risk of preeclampsia increase 
with increase in triglyceride concentration
51
.According to Cong KJ et al 
study ,compared to non pregnant women the increase in lipid level didnot 
occur in mid trimester of pregnancy,significant increase occur in late 
trimester.In his study,in normal late pregnancy and mild , moderate 
degree of  preeclampsia  on significant difference in lipid levels, but in 
severe preeclampsia serum triglycerides was significantly higher.Type IV 
hyperlipidemia  was seen in severe preeclampsia, because increase in 
serum triglyceride may result in lipid peroxide level elevation
17
. 
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Farah Khaliq et al concluded in his study that the levels of serum 
VLDL-C,triglyceride were significantly increased with parity.In his 
study,according  to parity subjects were grouped  into primigravida and 
multiparous.In subgroups of multiparous women lipid levels were 
compared, there was a significant increase in VLDL-C and serum 
triglyceride in preeclampsia women having  third or more pregnancy 
compared to second pregnancy. No other  lipids showed significant  
change
2
. 
Risto Kaaja et al concluded in his study that in preeclampsia  
metabolic characteristics resemble the features of “insulin resistance 
syndrome” (hypertriglyceridemia, hyperuricemia, low HDL2, 
hyperinsulininemia), which may result in endothelial dysfunction. In 
normal pregnancy, lipid profile changes  are physiological because of  
hormonal variation
5
. According to Chiang AN et al study the levels of 
serum LDL-C, HDL-C, serum triglyceride, serum TC, which is 
physiological  hyperlipidemia
18. 
         According to Belo L et al study,  there is rise in triglyceride and 
decrease  in the size of LDL with proportional increase of  small dense 
LDL which is atherogenic. But other studies concluded that physiological 
hyperlipidemia seen in normal pregnancy characterised by increase in 
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cholesterol, triglyceride. The alteration in levels of phospholipids, fatty 
acids,triglyceride,cholesterol are because of  changes in adipose tissue 
and hepatic metabolism and they are attributed to relative insulin 
resistance and high concentration of estrogen
19
.The rise in circulating 
triglyceride also explained by characteristic rise in the activity of hepatic 
lipase and reduced lipoprotein lipase activity
20
.There is decrease in 
clearance of triglyceride rich lipoproteins from circulation, due to 
decrease in the activity oflipoprotein lipase in adipose tissue
21
. 
RISK FACTORS
3,11,17,18 
1. It  is  common in  extremes  of  age (less  than  18  years  and  
more  than  35 years.) 
2. It is  2  fold  more in  black  women compared  to  white. 
3. Obesity 
4. Inadequate  diet like    deficiency  of  Zinc, calcium, vitamins  
C&E  and  n-3  essential  fatty  acids. 
5. Primigravida 
6. In multigravida  with   previous  history  of PIH   the  risk  
increases  by  40-50%. 
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7. Pre  -existing  medical  disorders  causing  increased  risk  are, 
a) Chronic  hypertension 
b) Hypercoagulable   states  like Anti-Phospholipid syndrome, 
Factor  5  Leiden mutation 
c) Diabetes  mellitus  
8. Genetic susceptibility-chromosomes 1,3,9,18   are  being  
implicated. 
9. Increased   gene  polymorphism   in  angiotensin  T235  allele  
gene, rennin   gene, IGF-2, gene  involved  in  lipid  metabolism 
10. Genotype  of  fetus -   paternally  and  maternally   transmitted 
11. Environmental   factors  
12. Conditions  associated  with   large  placenta   like  multiple  
pregnancy and  molar pregnancy  
CLINICAL FEATURES OF PREECLAMPSIA
17 
1.Hypertension: 
Rise of BP greater than or equal to 140/90 mmHg,or increase in 
systolic BP of 30 mmHg,increase in diastolic BP of 15 mmHg. 
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The rise in BP is due to excess pressor substances in circulation 
and vascular system showing increased sensitivity to them. 
2.Proteinuria: 
            In the 24 hours urine sample presence of protein more than 0.3 
gm,or in random urine specimen more than 1+(>30mg/dl) 
Glomerular afferent arterioles undergoes vasospasm lead to anoxic 
change and altered capillary permeability.That lead to protein leak in 
urine. 
3.Oedema&excess weight gain: 
In a week weight gain more than 1 Ib and in a month more than 5Ib 
in last trimester,after 12 hours of bed rest pitting edema over ankle may 
be earliest evidence of preeclampsia. 
Decrease in osmotic pressure because of proteinuria and capillary 
permeability increase  lead to development of oedema. 
4.Epigastric pain: 
In preeclampsia, there is hepatocellular necrosis that is the cause 
for epigastric pain. Stretching of glissons capsule and ischaemia 
aggravates pain. 
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5.Thrombocytopenia: 
             Due to severe vasospasm there is activation of platelet leading to 
platelet aggregation and microangiopathic hemolysis causes 
thrombocytopenia. 
6.Other symptoms: 
              Due to cerebral hyperperfusion headache and visual 
disturbance(blurring of vision) develops. Because of decreased renal 
blood flow and GFR reduced urine output develops. 
 Abnormality Mild Severe 
Diastolic BP <100 mmHg >110mmHg 
Proteinuria Trace to 1+ 2+ or more 
Headache 
Visual disturbance 
Epigastric pain 
Oliguria 
Absent 
Absent 
Absent 
Absent 
Present 
Present 
Present 
Present 
Serum creatinine Normal Elevated 
Thrombocytopenia Absent Present 
Liver enzyme elevation Minimal Marked 
Fetal growth restriction Absent Present 
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Table-1:Indicators of severity of preeclampsia 
Preeclampsia is  known  as“  Disease  of  theories”
3
.   It  is  
associated  with  multiple  organ  involvement, multifactorial   etiology, 
so  various   theories   were  proposed   in understanding  of  its   
pathogenesis
13
.  Even though  exact  etiology  remain  obsure, some  most   
accepted   hypotheses  are   abnormal   trophoblast   invasion  of  uterine  
vessels, increased   vasopressor  response ,vasospasm, immunological  
intolerance to  fetus  and genetic  abnormalities
3
. 
The  most   common  basic   abnormalities  consistently   seen  are 
a) Incomplete  invasion  of  cytotrophoblast  in to  spiral  arteries, 
b) Inflammation 
c) Immunological intolerance 
d) Endothelial  dysfunction 
A. ABNORMAL  PLACENTATION 
      Placenta    plays  a major  role  in  the  pathogenesis  of preeclampsia ,  
as it is proved  by  delivery of placenta  resolves  this  condition.  Severe 
preeclampsia  is associated  with   pathological  evidence  of placental  
ischaemia  and  hypoperfusion. This  states  to  “Two  stage  theory”. That  
theory  explains   preeclampsia  as  a  systemic  disorder with  
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characteristic  origin  in  the placenta and associated with  maternal  
widespread  endothelial   dysfunction  & vasospasm   and arterial 
constriction lead to  reduced  intravascular  volume  compared to normal  
pregnancy
3
. 
Abnormal placentation  as a cause  of   placental  ishcaemia  and  
hypoxia 
   Normally  during  placental  development  maternal  spiral  
arteries  are  invaded by   invasive  cytotrophoblast  of  the  fetal  origin 
that  leads to  transformation of   small calibre  resistance  vessels  to   
high  calibre   capacitance  vessels capable  of  maintaining  adequate  
placental  perfusion to   growing  fetus. During  vascular  invasion a 
specific  process named  as”Pseudovasculogenesis  or   Vascular  
mimicry”  occurs
3,4,12
 . That  means    differentiation  of  cytotrophoblast   
from   epithelial  phenotype  to  endothelial phenotype
3
. 
In  Preeclampsia   this  event  fails to occur ,so   cytotrophoblast  
are  not  converted to  endothelial  type. At  the  same  time  invasion  
also   shallow, so  spiral  arteries remain  as  small  calibre  resistance   
vessels. Switching  cell surface  molecules  over  the  surface  of  
cytotrophoblast  fails to  occur, because of  that  they are not  able  to 
invade  the spiral  arteries  that  lead to  placental  ischaemia  and  
hypoxia
10
. 
 
 
36 
 
This  vascular   remodelling  process starts  around  10-12  weeks  
of  gestation  and is  completed    by 18-20   weeks  of pregnancy.This  
invasion   extends  from  decidua   to  inner  third of myometrium. But in 
Preeclampsia  only  decidual  vessels  are   lined  by  endovascular    
trophoblasts
17
 .Vessels of   myometrium  are  not  invaded, so  deep  
myometrial  vessels do not lose their   endothelial  lining  and  
musculoelastic  tissue, because  of  that vessels  mean  external  diameter 
is  reduced  half  than  normal  placental  vessels.This  lead to    reduced  
uteroplacental  blood flow and  because of  diminished  perfusion   
hypoxia. Hypoxia  leads to  release  of  placental  debris  that  creates  
systemic  inflammatory response. 
 
Figure-4:Difference in invasion of  trophoblast  among normal 
pregnancy&preeclampsia
17
. 
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On  examination  under  electron  microscope fibrinoid  material  
occludes  the arteries  at  the  implantation   site  and  there  was  medial  
necrosis. First  in the myointimal  cells  lipid  accumulation  occurs  then  
in the  macrophages. This is  termed  as atherosis
25
.In placental stem 
vessels there is atheromatous changes and degeneration of 
endothelium,all this leads to progressive fibrosis and lumen obliteration. 
Placental perfusion is diminished because of all this changes and lead to 
preeclampsia syndrome
25
. Acute  atherosis  and thrombosis   leads  to  
placental  infarct ,which  are  common in  preeclampsia. 
 
Figure-5: Endothelial degeneration and atheromatous   plaque 
formation  in umbilical vessels –Villi of preeclamptic 
placenta(H&EX100)
35 
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   Eventhough  the  pathology of  Preeclampsia  starts  at  placenta 
the  ultimate  target  is  maternal  endothelium. Placental  ischaemia  leads 
to  release of  factors or substances  into  the  systemic  circulation  that 
causes  endothelial  injury. So, in Preeclampsia    many  serum markers  
of  endothelial  activation  and  dysfunction   like   platelet  derived  
growth  factor(PDGF), endothelin, soluble   tissue  factor, soluble  E-
selectin, cellular  fibronectin, von willebrand  factor  are  deranged
17
. 
2.Inflammatory   changes  of  normal  pregnancy
17 
In normal  pregnancy: 
a) There is reduction in the synthesis and secretion of  inflammatory  
cytokines. 
b) Placenta secretes angiotensinase enzyme that destroys 
Angiotensin-2 . 
c) There is increased vascular synthesis of VEGF, (PGI2) 
Prostacyclin & nitric oxide (NO), the potent vasodilators  and  
inhibitors  of platelet  aggregation. Because  of  this  changes  
vascular  system  shows  decreased  response  to  pressor agent. 
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In  Hypertensive  disorders  of  pregnancy: 
a) Because of decrease in activity  of  Angiotensinase enzyme,  
there  is  increase  in  half life  of  Angiotensin-2 occurs. The  
sensitivity  to  Angiotensin-2 also   increases. 
b) Activated leucocytes  release  inflammatory mediators  like TNF-
a&IL-6 that substances  act  directly  and also  indirectly  by 
inducing  oxidative   stress cause  endothelial  injury. 
c) Human  endothelium  produces  potent  vasoconstrictors like  
endothelin. Even though   in normal pregnancy  itself  their  
levels  are  elevated, in Preeclampsia levels  are  very  much  
higher  than  normal pregnancy. 
d) In Vascular   syncytiotrophoblast and  endothelial  cells   
L-Arginine   synthesizes   nitric oxide. Nitric oxide is a potent  
vascular  smooth  muscle  relaxant ,inhibitor  of  platelet  
aggregation. It  also  prevents  thrombosis   in intervillous   space. 
e) In platelet, there   is increased  synthesis  of  vasoconstrictors  
like  thromboxane A2 , but  reduced   synthesis of  vasodilators 
like prostocyclin. 
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The sum of  over all changes  is  increase  in  vasoconstrictors &  
decreased vasodilators  and  elevated  response  to  pressors. All   this  
leads  to  platelet  aggregation  and  endothelial  dysfunction.  
 
                                 Elevated lipids 
                         
                  Atherosis and triglyceride related vasculopathy in placental 
bed vessels                                      
 
                             Placental ischaemia 
 
                                           
                                         Placental  oxidative  stress 
 
 
Fetal  growth                                     Systemic  release of placental  
Restriction                                                factors 
                                                                                                                                                 
 
Systemic inflammatory response, endothelial activation 
 
 
Preeclampsia syndrome 
 
Figure-6:Role of dyslipidemia in development ofpreeclampsia 
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3.Immunological  intolerance
17
: 
Compared  to  normotensives women  destined  to  develop  
preeclampsia   have   lower  proportion  T-Helper  cells  in  eary  second  
trimester  itself. There   is  imbalance   in Th1/Th2  ratio . There  is  
predominance  of  Th1  cells, that   leads  to secretion of  cytokines  
which  causes  inflammation. 
The  maternal  immune  tolerance  to  paternally  derived  placental  
or fetal  tissues  are  dysregulated  and lost,   that  lead to changes at 
placental  surfaces   which  is  suggestive  of  acute  graft  rejection. The  
ratio   of  maternal  blocking  antibodies  to  placental  antigenic sites  and  
fetal  antigenic  sites  are  not  in balance  in  preeclampsia. In  support of 
this, the  incidence of preeclampsia  is  more    in multiple pregnancy, 
molar  pregnancy (excess of fetal antigenic load) and   nulliparity 
(absence  of  blocking  antibodies).So in  immune suppressed  states  and  
in  consanguineous  marriages   the  incidence  is  decreased. 
4.Endothelial  dysfunction: 
In  several  tissues  including kidney and placenta  to  maintain  
endothelial  health VEGF and  TGF-b1 are  needed. The regulators  of   
vascular  hemostasis  in normal  pregnancy  are  VEGF  ,TGFb1. Levels  
of  VEGF  ,TGE-b1   are  decreased  in preeclampsia  because  of  excess  
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secretion of  S-flt and  S-eng. Production  of  nitric  oxide  and  
prostacyclin  also  reduced. All this changes  lead  to endothelial  
dysfunction. 
At  the site of  endothelial injury, 
1. Increased  membrane  permeability 
2. Increased procoagulants synthesis, decreased  anticoagulants  
synthesis 
3. Promotion of  platelet aggregation 
4. Clot  formation, vasospasm 
This is mechanism operating in both preeclampsia and  atherosclerosis. 
Figure7-: In Hypertensive disorders of pregnancy,pathophysiological 
role of endothelial dysfunction
32 
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In pathogenesis of preeclampsia, role of  lipids in endothelial  
dysfunction 
One of the predisposing factor in mother that lead to development 
of preeclampsia is constitutional lipid abnormalities
14
.  Lipid  metabolism 
abnormality  is not a mere manifestation,but various lines of evidence 
indicate that it is involved in pathogenesis of preeclampsia.Oxidative 
stress due to lipid  causes hyperstimulation of endothelium which may 
lead to dysfunction and damage. 
In most recent studies  it was stated that women in first and second 
trimester there is elevation of triglycerides and free fattyacids.In vitro 
experiments reported in preeclampsia plasma  the endometrial stimulatory 
activity depend on lipid fraction.Recent studies shown that there is 
predominance of atherogenic small dense low density lipoprotein(LDL) 
in preeclampsia women,which is characteristic of atherosclerosis
14
 
The association between endothelial dysfunction  and lipids  in 
preeclampsia could be oxidative stress.By different enzymatic process 
freeradicals are generated.Free radicals are extremely reactive and they 
interact with polyunsaturated free fattyacids & produces lipid peroxide. 
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PATHOLOGICAL CHANGES IN DIFFERENT SYSTEMS
32
 
Various significant changes in different organ systems in body 
takes place in gestational hypertension and preeclampsia. 
1.BRAIN: 
            In hypertensive disorders of pregnancy brain damage is explained 
by two theories. 
a) Because of extravasation of plasma through endothelial capillary 
leak during sudden increase in systolic BP 
b) Vasospasm due to cerebral autoregulation during sudden rise in 
BP lead to cerebral ischaemia,ifarction,oedema. 
This changes causes headache,blurring of vision, convulsion, 
confusion, coma. 
2.CARDIO VASCULAR SYSTEM: 
            Because of vasoconstriction and hypertension causes increase in 
afterload and due to expansion of blood volume increase in preload 
occurs,all this changes predispose to increase in left ventricular 
mass.Conducting system may affected due to changes in the myocardium 
like necrosis at focal areas and hemorrhage that may lead to cardiac 
failure. 
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3.KIDNEY: 
          In kidney characteristic change known as “Glomerular 
endotheliosis” occurs.It consist of swelling of endothelium,cytoplasm 
hypertrophy and vacuolization.Due to this changesthere is reduction in 
renal blood flw,GFR,tubular absorption and secretion occurs. 
4.LIVER: 
     From areas of infarct hepatic hemorrhage may extend and forms 
various degrees of ischaemic damage,periportal hemorrhage,thrombosis 
of portal vessels,subcapsular hematoma.Elevation of liver enzymes ocuur 
due to necrosis of parenchyma. 
5.HELLP SYNDROME: 
In severe preeclampsia HELLP syndrome occurs,due to 
hepatocellular necrosis.The components of HELLPsyndrome are 
hemolysis(intra vascular).rise in liver enzymes,thrombocytopenia. 
6.BLOOD AND COAGULATION: 
          Various changes occuring in this system are there is increase in 
formation of intravascular thrombin and decrease in platelet count and its 
life span and rise in thromboxane A2 due to excess degranulation. 
Endothelium releases PAI  and fibronectin that lead to DIC.DIC is 
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characterised by thrombocytopenia due to platelet consumption and 
decrease in hemoglobin,schistocytes in peripheral smear due to 
microvascular hemolysis. 
7.DYSLIPIDEMIA AND INSULIN RESISTANCE
34
: 
There is decrease response to circulating insulin by 
liver,muscle,adipose tissue.Normal pregnancy is characterised by 
increase in insulin levels and peripheral resistance to insulin.Due to 
hormonal changes  like rise in estradiol,progesterone,cortisol,human 
placental lactogen there is insulin resistance,which is maximum in third 
trimester.In preeclampsia,this changes are exaggregated as evidenced by 
various biomarkers like leptin,decreased sex hormone binding 
globulin,PAI-1. Changes in lipid profile occurs due to insulin resistance. 
That leads to atherogenic lipid profile which is characterised by rise in the 
total cholesterol,free fatty acids, triglycerides, small dense LDL and 
reduced HDL cholesterol. In the pathogenesis of preeclampsia 
atherogenic lipid profile plays a vital role. 
8.ENDOCRINE SYSTEM
36
: 
Because of enlargement of pituitary  there is increase levels of  
growth hormone occurs. Placental growth hormone which is secreted by 
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syncytiotrophoblasts, the difference between the two is 13 amino acid 
residue. Insulin resistance is determined by placental growth hormone. 
Due to glandular hyperplasia and vascularity increase there is 
enlargement of thyroid gland. In pregnancy HCG levels are also 
increased. Due to structural similarity between HCG and TSH there is 
increase in thyroid hormones(T3,T4) occurs that leads toinsulin resistance. 
In Preeclampsia there is increase in levels of aldosterone,ANP and 
cortisol seen.Vascular system shows increased sensitivity to renin and 
angiotensinII. 
PREDICTORS  FOR  PREECLAMPSIA
36,37 
There  are  various   biochemical  and  clinical  tests  are  proposed 
for  prediction  in early pregnancy. Even though  various  test  are  
available, there  is  no simple, reliable and   valid  screening  test. 
Predictors  are  classified  as: 
     a. Non  - laboratory  methods. 
      b. Laboratory  methods. 
a . Non  laboratory  methods: 
1. History & Examination 
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• Nulliparity 
• Past  history  or  family  history   of  hypertensive disorder 
2. Blood pressure  monitoring: 
          Mean  arterial pressure  in  early  pregnancy 
3. Pressor  Tests: 
a) Roll over  test: 
After   measuring  BP  in  lateral  position, Patient  is  asked to  
rolled  over  to supine position. The   test is  said  to  positive  when  there  
is  rise  of 20mmHg  or  more  than  normal. But  it   has  poor  sensitivity  
and   specificity. 
b) Isometric  exercise  (Hand  grip)  test: 
In hand grip test the increase in systolic BP of 15mm Hg predicted 
the development of preeclampsia with high sensitivity(81.8%) and 
specificity (68.4%). But the test has poor reproducibility. 
c) Angiotensin  sensitivity  test: 
          It is  a screening  test  based  on degree  of  sensitivity  to  
angiotensin. The  patient  are  destined  to  develop  to  preeclampsia may   
have abnormal  vascular   reactivity. That  may  be detected   several  
weeks   before  manifestation of  disease. In  this  test  to   raise  the   BP  
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to  20mmHg  the  dose  of  angiotensin-2 needed is  calculated. This  test  
also  has  low  sensitivity  and  specificity. 
3. Doppler velocimetry: 
To  evaluate   diminished placental  perfusion  and  uterine  artery  
resistance  Doppler examination     of   uterine  and  umbilical  arteries  
are  used. 
b) Laboratory  tests: 
1. Micro albuminuria: 
          Urinary  excretion  of  albumin  more  than  300 mg  in 24  hours  is 
labelled  as micro albuminuria. Detection of microalbuminuria  in   
second  trimester  is a good  predictor. 
2. Urinary  calcium /creatinine  ratio: 
            Preeclampsia  is  associated    with  hypocalciuria, due  to  
increased   tubular  reabsorption   and decreased  renal  filteration. So,  
decreased calcium/creatinine  ratio   is seen in  preeclampsia. The   
sensitivity  of this  is  70% and  specificity  is  95%. 
3.Serum   uric  acid : 
          Preeclampsia  is  associated  with   reduced   glomerular  filteration,  
increased  tubular  reabsorption, decreased  tubular   secretion. So  serum  
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uric acid  level  are  elevated   in  preeclampsia. But   it  is  not  sensitive  
and  specific. 
4.Serum  Fibronectin: 
        Following  endothelial  injury, endothelial  cells release fibronectin  
which   is  a  glycoprotein  and  constituent  of   connective  tissue& 
basement   membrane  involved  in  cellular  adhesions. In  normal  
pregnancy  during   third  trimester 20%  rise in serum  level  occurs. But  
in preeclampsia the rise is  more. 
5. Serum  Antithrombin: 
Even though  the  levels  of  Antithrombin are   reduced  in   
preeclampsia, there  is  overlap in   levels  in  between   hypertensive  and  
normotensive. 
6.Free  fetal  DNA: 
The  main   component   involved  in pathogenesis  of  
preeclampsia are endothelial  activation, placental  ischaemia and  
inflammation all lead to  apoptosis. Because  of  accelerated    apoptosis 
free  DNA are released  in   circulation. 
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7. Oxidative  stress: 
          As preeclampsia  is  associated  with   vasospasm, there  is  
oxidative    stress  that  leads  to  increased    lipid  peroxides. 
8. Homocysteine: 
                 Preeclampsia is  associated  with  hyperhomocystinemia    that  
causes  endothelial   damage &  oxidative  stress. 
9. Cytokines: 
          Preeclampsia  is  associated  with  elevation  of  cytokines  which  
are  released    by  vascular  endothelium and macrophages , leucocytes. 
But   they  are  non specific    because  they  are  also  elevated  in  
inflammatory  diseases  and  infections. 
10. Coagulation  activation: 
           Because  of  endothelial  injury,vasospasm   and  platelet  
aggregation    preeclampsia  is associated with platelet   dysfunction  and  
thrombocytopenia. 
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COMPLICATIONS OF  PREECLAMPSIA
17
 
a. Accidental Hemorrhage 
b. Acute renal failure 
c. Cerebro vascular accid 
d. HELLP syndrome 
e. Microangiopathic hemolytic anaemia 
f. Acute lef tventricular failure with pulmonary edema 
g. Eclampsia 
h. Aspiration pneumonia 
i. Preterm labour 
j. Sepsis &Shock  
k. Recurrence of Preeclampsia in next pregnancy 
l. Metabolic syndrome at later life-They are prone for diabetes, 
Hypertension at later life 
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FETAL COMPLICATIONS 
a. Intra uterine death  
b. Prematurity 
c. Intra uterine growth restriction-due to chronic placental 
insuffiency. The duration of  hypertension is more important than 
the level of blood pressure. 
d. Neonatal encephalopathy-The link between preeclampsia and 
neonatal encephalopathy is a systemic inflammatory response 
secondary to oxidative stress. 
e. Antepartum and intrapartum asphyxia due to impaired placental 
flow lead to anoxia 
PREVENTION OF PREECLAMPSIA 
METHODS PROPOSED TO PREVENT PREECLAMPSIA  
1. Salt restriction 
2. Antioxidants 
3. Fish oil supplementation 
4. Calcium supplementation 
5. Low dose aspirin 
6. Heparin 
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1.SALT RESTRICTED DIET 
Though the  earliest research efforts proposed that restriction of 
salt prevent the development of preeclampsia,but recent studies proved 
that it is ineffective in preventing the development of preeclampsia
45 
ANTIOXIDANTS 
Preeclampsia is associated with increased oxygen free radical and 
decreased antioxidants. The level of oxygen free radical are decreased 
byantioxidant vitamins like vitamin-C, vitamin-E. But the levels of this 
vitamins are decreased in women at risk for developing preeclampsia. 
So,to increase the oxidative capacity vitamin-C, vitamin-E are provided. 
Recent trials proved that antioxidant supplementation in antenatal 
women does not decrease the incidence of preeclampsia compared to 
placebos. 
However two recent studies (Poston et al and Rumbold et al 
2006) on role of Vit C(1000 mg)and Vit E 400 IU per day have shown 
little benefit and potential for harm
53,54
. 
3. FISH OIL SUPPLEMENTATION 
It is the common dietary source of alpha-linoleic acid (ALA), 
eicosapentaenoic acid (EPA). It was supplememented with the 
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proclamation that , these fatty acids would prevent atherogenesis due to 
inflammation. But recent studies showed that no beneficial effect on 
supplementation
. 
Makrides et al (2001) have clearly shown insufficient evidence it 
for prevention of preeclampsia
46
.
 
4.CALCIUM SUPPLEMENTATION   
Women who consume low calcium diet are at risk of developing 
preeclampsia, was postulated by studies performed outside united state 
at1980’s. Number of trials regarding calcium supplementation proved 
that supplementation has no salutary effects unless women is calcium 
deficient. 
Some studies have shown decreased incidence of preeclampsia 
with calcium supplementation of 1.5-2 gms/day. Historically also a 
relationship between calcium deficiency and preeclampsia was suggested. 
(Villar et al 2006)
51 
Recently Cochrane systematic review noted protective effects of 
calcium supplementation only in women with low calcium intake 
(Hofmeyr 2000
52
).WHO(2006) published results of a large multicentric 
randomized place to controlled trial of calcium supplementation in 
pregnant subjects with lowcalcium intake(<600 mg/day). 
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Supplementation with1.5 gm of calcium/day did not result in statistically 
significant decrease in overall incidence of preeclampsia. 
5.LOW DOSE ASPIRIN 
There is inhibition of synthesis of thromboxane (TXA2)in platelet 
by low dose aspirin, but action on PGI2 is minimal. Dose is 50 to 150 mg 
daily.In meta analysis of 31 randomised trials  the women consumed 
aniplatelet agents the relative risk of preeclampsia reduced significantly 
by 10%. Paris Collaborative Group trial - (CLASP, 1994; 
COMMARASAMY A 2003 ; CARBILLON 2005) showed that the use 
of aspirin decrease the relative risk of PIH by 10 percent
48,49,50
.   
6.HEPARIN 
           Because of high prevalence of placental thrombotic lesions found 
withsevere preeclampsia, there have been several trials to evaluate 
heparin treatment for affected women. Prophylaxis with loe molecular 
weight heparin plus low dose aspirin on pregnancy outcomes in women 
with a history of severe early onset preeclampsia and low birth weight 
infants. There were better pregnancy outcomes in women given low dose 
aspirin plus low molecular weight heparin compared with those given low 
dose aspirin alone
47
. 
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SERUM   LIPID  PROFILE 
LIPOPROTEINS: 
Lipoproteins   are  spherical  particles  with   free   or  non-
esterified   cholesterol and  triglycerides  on their surface  as  amphipathic  
coat and  core   contains   triglycerides  and  cholesterol  esters which  are 
hydrophobic  lipids. 
 
Figure-8 Structure of lipoprotein
55 
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Classification of lipoproteins:
57 
Lipoproteins are mainly classified into five groups according to 
their density on ultracentrifugation and their mobility on electrophoresis. 
 - Chylomicrons  
 - Very low density lipoproteins (VLDL) 
 - Intermediate density lipoproteins (IDL) 
 - Low density lipoproteins (LDL) 
 - High density lipoproteins (HDL) 
1.CHYLOMICRONS: 
Chylomicrons  are  made   of  mainly   triglycerides  with  
cholesterol and   specific  apolipoproteins  ApoB-48,ApoA-1,A-2,C-1,C-
2,C-3. 
Metabolism: 
In intestine synthesis of chylomicrons takes place. By  
chyomicrons  exogenous/dietary  triglycerides    are  transported  to   
skeletal   muscles   and   adipose  tissue and  dietary   cholesterol   are  
transported  to  liver. 
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In  intestine  fat  in  diet  are  converted  to   monoglycerides   and  
free  fatty  acids and absorped   in to  villi. In  villi   they  are   converted  
to  triglycerides.  In   golgi  apparatus   and  smooth  endoplasmic  
reticulum   triglycerides    combined  with   cholesterol  esters.In  rough  
endoplasmic  reticulum    ApoA-I  ApoA-II and  ApoB-48    which  are  
combined  with  lipids  and  form  chylomicrons   in  intestinal  cell. This  
chylomicrons  are  absorped   in  to  lymphatics  and  thoracic  duct   then  
to  systemic  circulation. While in  circulation  chylomicrons  combined  
with  ApoE  and  Apo C and  form  mature chylomicrons. 
Through systemic circulation they enter peripheral tissues. ApoC-II 
activates lipoprotein lipase present in capillary endothelial cells   which 
causes  hydrolysis of  triglyceride  core  of  chylomicrons leaving   
chylomicron  remnants. During  hydrolysis   phospholipids  ,cholesterol  
and  ApoC  from  the   surface  are  transported  to   HDL particle. 
Cholesterol ester, ApoB-48 and ApoE are present  in  chylomicron  
remnant. ApoE is responsible for chylomicron remnant uptake by high  
affinity  hepatic   receptors. Hepatic lysosomes Cholesterol ester, Apo  B-
48 and ApoE are present in chylomicron  remnant. ApoE is responsible  
for chylomicron remnant  uptake by high  affinity  hepatic receptors. 
Hepatic lysosomes degrades it. Chylomicron remnant are having 
atherogenic  potential. 
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Figure-9     Chylomicron   metabolism
58 
2.VERY LOW DENSITY  LIPOPROTEINS
56,59
:
 
Triglycerides, cholesterol, phospholipids  and proteins   are 
 
present  
in  VLDL. Apo   B-100,C-I,C-II,C-III,Apo-E -II,E-III  and E-IV are  
apoproteins  present  in  VLDL
59
.
 
Metabolism: 
In  peripheral  tissues glucose  and  chylomicron  remnant-TG  are  
not  hydrolysed, which  are   utilised  for  hepatic  VLDL-TG  synthesis. 
This  is  evidenced  by   post  prandial   rise  in  chylomicron-TG and  a 
secondary  rise in  triglyceride  concentration  4-6 hours  after  meal
59
. 
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TG, cholesterol, Apo B-100, Apo  E and Apo  C  are  present in   
nascent  VLDL . Apo C-II   on  VLDL’s  surface  activates   lipoprotein   
lipase   present  on  endothelial   cells, which  causes   hydrolysis  of  
VLDL-TG  and   releases   free  fatty  acids. 
VLDL particles    are   converted  to    VLDL   remnants  because  
of   transfer  of  Apo  C  to  HDL  during   hydrolysis. Thus  formed  
VLDL  remnant  are  known  as  intermediate  density  lipoproteins. 
3. INTERMEDIATE  DENSITY  LIPOPROTEIN(IDL)
59
: 
During  VLDL  catabolism   IDL   are  derived. Through   Apo-E  
mediated   process  IDL are   taken  by  liver. Lecithin   cholesterol   acyl  
transferase(LCAT)  in  plasma  catalyses  esterification  of  free  
cholesterol  of  HDL with fatty  acids   derived  from  lecithin  which  is  
major   phospholipid  in   plasma  membrane. Through  the  action  of    
plasma  cholesterol exchange  protein  this    newly   synthesized    
cholesterol  is  transferred  to  IDL .Most  of  original  TG  core  of  
VLDL  are   replaced  with   cholesterol  ester. 
IDL  particle  from  capillary  wall  are   released  in  to  circulation  
after   hydrolysis. Then   because  of  further  conversion   remaining   
TG’s  and  apolipoproteins   except     Apo B  are lost  lead  to  production  
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of  LDL  which  contains  pure  cholesterol  ester  in  the core  and  Apo  
B   at  the  surface. 
Figure-10 Metabolic fate of VLDL and LDLproduction
55 
4.LOW  DENSITY  LIPOPROTEIN(LDL)
59
: 
Cholesterol, phospholipids  and  triglycerides  are   component  of   
LDL. LDL  is  major  carrier  of  cholesterol  which   formed   from  
breakdown  of  VLDL. LDL   is   the  atherogenic  lipoprotein. LDL-B  
(small  dense particles) and  LDL-A(large  buoyant   particles) are  the  
two  sub fractions   of LDL. 
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Compared  to  LDL-B   which  are formed  from  LDL-A ,LDL-A  
contain  more  cholesterol   ester .Higher  small dense   LDL   particles  in  
plasma makes  the  patient  more  prone  for  preeclampsia
60
 .   
Metabolism: 
Delivery of  cholesterol   to  extra  hepatic  tissue  and  liver  is  by  
LDL. 
LDL  binds  to    clathrin  coated  pits which  are   high  affinity  
receptors  present   at  extra hepatic  tissues. After  binding   endocytic  
vesicle   are   formed  by   invagination  of  pits  into   the cell. Endocytic  
vesicle  fuse  with  lysosome  and  LDL  released  from  receptor  because  
of  acidic pH. In lysosomes     degradation  of  Apo B  to  small  peptides  
and  aminoacids and  degradation  of  cholesterol  takes  place. For  the  
synthesis  of  cell membrane and steroid  hormones   the  cholesterol  
liberated  are  used. 
The  cholesterol supplied  is regulated  at  cellular  level. Increased  
level  of  cholesterol  lead  to: 
a) Activation of enzyme   acyl  cholesterol  acyl  transferase  
(ACAT)  and increased  formation  cholesterol ester  occurs.  
b)  Inhibition  of  HMG CoA  reductase     and  decreased rate  of  
endogenous  cholesterol  synthesis. 
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c) Suppression  of  gene  transcription  causes   inhibition  of       
synthesis   of   new  LDL  receptors
56
.  
 
Figure-11: Factors   affecting  cholesterol  balance  at the  cellular level
61 
5. HIGH DENSITY  LIPOPROTEINS: 
Smallest  and  densest   of  the lipoproteins is  HDL because  of  
it’s  high  protein  content which    forms   50%  of  it’s  mass. Among  
the   total   protein  content  70%  formed  by  Apo A-I  which  plays  a 
major  role  in  esterification of  cholesterol  catalysed  by  Lecithin  
cholesterol  acyl  transferase
59
. 
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In  liver  and  intestine  synthesis  of  HDL  takes  place. In  liver 
synthesis   of  Apo  C  and  Apo   E  takes  place, which are  required  for  
chylomicron and  VLDL  mechanism, HDL  acts  as  a repository  for   
them. 
The  component  of  nascent  HDL   is  discoid  phospholipid  
bilayer which consist  of  Apo-A and  free  cholesterol. Apo-A I  activates   
LCAT, which  converts  surface  phospholipids  and free cholesterol  in to  
cholesterol  ester and  lysolecithin. Cholesterol  ester  which  are  
nonpolar  goes  into  hydrophobic  interior of  bilayer  and lysolecithin  is  
transferred  to  plasma  albumin. Spherical  pseudomicellar  HDL-3  is  
formed  by   non polar  core  covered  by a  surface  film  of  polar   lipids 
and  apolipoproteins. From  peripheral  tissues   via  scavenger  
receptor(SRB-1) and  ATP  binding   cassette  receptor G-1(ABCG-1) 
cholesterol  transferred  to  HDL-3 ,then  LCAT  esterifies  the  
cholesterol and  increases it’s  size and  forms  less dense HDL-2. By  
SRB-1 from   HDL-2 cholesterol  ester  are delivered   to liver which  is 
called  as  “reverse   cholesterol  transport”. Hepatic  lipase  hydrolyses 
the  phospholipids   and  triglycerides  and forms  HDL-3, this HDL-2 
and  HDL-3  interchange is  called  as HDL  cycle
56,59
. 
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Figure-12: Metabolism   of  HDL  and  reverse cholesterol  
transport
55 
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METHODOLOGY 
 
A cross  sectional  study  of lipid profile  was conducted  taking  
women  with  gestational  hypertension  and  preeclampsia  as  cases  and 
healthy  pregnant  women  as  controls  from  November 2012  to October 
2013. The  study  was  conducted  in Department  of  obstetrics  at   
Coimbatore  medical  college. It  was   approved  by Ethical and  
Research  Committee   of  Coimbatore   Medical  College. Informed   
consent  was  taken  from each participant. 
1.  Selection  of  study  subjects: 
A  total  number  of   90 subjects   were  selected on  the  basis  of  
inclusion  and  exclusion   criteria. Patient’s data  and  relevant  
information  were  recorded  in  a proforma. 
Cases: 
60  women  with  Hypertensive  disorders  of  pregnancy  were  
selected  on  the  basis  of  definitions given  by  National High blood 
pressure education programme (NHBPEP 2000) Case subjects were 
divided into two groups. 
Group I-30 diagnosed cases of Gestational hypertension in age 
group of 20-30years.  
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Inclusion criteria: Pregnant female of 28-40 weeks of gestation 
with blood  pressure _140/90 mm of Hg noted first time during pregnancy 
on _2 occasions at least 6 hours apart without proteinuria was considered 
as having gestational hypertension. 
Group II- It included 30 diagnosed cases of preeclampsia in age 
group of 20-30 years. 
Inclusion criteria:  
Pregnant female of 28-40 weeks of gestation with blood pressure 
_140/90 mm of Hg noted first time during pregnancy on _2 occasions 
atleast 6 hours apart with proteinuria of _1+ ( _30mg/dl) by dipstick 
method in arandom urine sample was considered as having preeclampsia. 
Control group- It included 30 pregnant women. 
Inclusion criteria:  
Age matched healthy pregnant women of 28-40 weeks of gestation 
without any major illness and who are not on any medication were 
included. 
Exclusion Criteria: 
The pregnant women with following history were excluded from 
the study: 
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• History of chronic hypertension that was present before 
pregnancy. 
• History of diabetes mellitus and/or who are on insulin therapy or 
hypoglycaemic drugs. 
• Obese women with pre pregnancy BMI > 25 
• Those who are taking antihypertensive or hypolipidemic drugs. 
• Those with diagnosed liver, cardiac or renal diseases or any other 
major illness. 
Sample collection is a invasive procedure performed in the study. 
The need for overnight fasting was explained to the controls and subjects. 
Informed consent was taken. While conducting the test subjects and 
controls were treated with due respect. 
Detailed history about present pregnancy and previous pregnancy 
incase of multi and past history and family history of diabetes, 
hypertension, renal disease, thyroid disorder and any chronic drug intake 
was obtained. Height and weight during first trimester noted from 
antenatal card, weight gain also made from antenatal records. 
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BMI was calculated as per formula: 
 Weight(Kg)/Height in meter
2 
Blood pressure was measured by palpatory method and 
auscultatory method in supine and sitting position.Systolic BP  was taken 
by Korotkoff sound(phase I) and diastolic BP was taken by Korotkoff 
sound (phase V)
17
. 
Diagnosis of hypertension  was made when systolic BP greater 
than 140 mmHg and Diastolic BP greater than 90 mmHgafter 20 weeks 
of gestation first time during pregnancy,after taking one more reading six 
hours later.   
         Then relevant investigations like blood urea,creatinine,blood 
sugar,serum uric acid, liver function test, complete hemogram, urine 
albumin were done. 
Estimation of urine albumin by Dipstick method 
Bottle with a tightly fitting cap contains reagent urine strips.It has 
several separate reagent areas affixed on plastic strip. Within 1 to 2 
minutes it produces colour change of standardized range, when analytes 
reacts with specific reagent area on the test strip. 
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Testing method: 
Under aseptic precautions freshly voided urine 2 ml is collected in 
a bulb. If patient is on urinary catheter, from indwelling catheter urine 
sample is obtained . From the air tight sealed containers dipsticks are 
removed, without touching the reagent areas of thestrip, to avoid 
alteration in test results.  
After dipping the reagent area in urine, excess urine to be removed 
by tilting the strip and to allow the urine to run off the edges. It prevents 
the mixing of reagents and their dilution. 
Principle of urine albumin test: 
It is based on “protein error of pH dye indicator”, principle using 
bromphenol blue. Whenever protein (albumin) present in urine, because 
of its negative charge there is increase in pH and positive result occurs 
Positive reaction is interpreted by development of range of colour 
from yellow to green then to blue. Yellow is interpreted as negative. 
colour change through yellow green and then green to green blue for 
positive reaction. 
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Test area Results Negative Traces Positive 
Protein Conc(mg/dl)   0 10 30 100 300 1000 
1+ 2+ 3+ 4+ 
 
Table-2: Sensitivity/limit of detection of Dipstick test 
METHOD  OF  COLLECTION OF  DATA: 
Blood  samples   are  taken    from  antecubital  vein   after     
overnight  fasting  and  collected   in  red capped   vacutainer  tube  which   
contains  clot activator. The  tube  was  kept  at  room  temperature  for 
half  an hour  for  clotting  and  then  centrifuged  at  1200rpm  to separate  
the serum  which  was analysed  using  Siemens  dimension  RxLMaX. 
Following  parameters  were  analysed: 
ESTIMATION  OF TOTAL  CHOLESTEROL
58,59
: 
Method: Enzymatic cholesterol oxidase – Phenol aminoantipyrine 
method
59
. 
PRINCIPLE:  
The   total  cholesterol  concentration  is  directly  proportional  to   
N,N  diethyl   aniline-Hcl/4-aminoantipyrine(DEA-HCL/AAP), formed at 
the end of reaction. 
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Cholesterol   esters 
	

	   



cholesterol   +  fatty  acids 
Cholesterol +
	

	   

 cholest-4-ene 3-one +  H2O2 
2  H2O2 + 4-Aminoantipyrine + Phenol



 Quinoneimine+ 4H2O   
ESTIMATION  OF  HDL  CHOLESTEROL: 
Method: 
Phosphotungstic acid and enzymatic cholesterol oxidase-phenol 
aminoantipyrine (CHOD-PAP)
58
  
Principle:  
               On mixing  the  sample with  phosphotungstic  acid and  
magnesium,chylomicrons,VLDL  and  LDL  are  precipitated. On  
centrifugation ,HDL  lies  in supernatant  portion  which  is  measured  by  
CHOD-PAP  method. 
Serum 
   !
 HDL(supernatant) +LDL, VLDL, chylomicrons (precipitate down)  
ESTIMATION  OF  SERUM  TRIGLYCERIDES: 
Method: 
Enzymatic glycerol phosphate oxidase – Phenol aminoantipyrine 
method
58
. 
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Principle: 
The  red  coloured  quinoneimine   was  measured   at 505 nm,the  
intensity  of which  is directly  proportional  to triglyceride  
concentration. 
Triglycerides + H2O
"##
$ 	#

  Glycerol + Free fatty acid 
Glycerol + ATP   
%&'()& * (
   Glycerol-3-phosphate + ADP 
                         
Glycerol-3-phosphate 
%&'()&+,+ ( -! (
 H2O2+Dihydroxy acetone phosphate 
2 H2O2 + 4-Aminoantipyrine + Phenol      
.()-! (
       Quinoneimine + 4 H2O 
ESTIMATION  OF  LDL  CHOLESTEROL
58
: 
Friedwald’s formula 
 LDL(mg/dl)=totalcholesterol(mg/dl)-HDL(mg/dl)-triglycerides(mg/dl)/5 
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RESULTS 
 
STATISTICAL ANALYSIS: 
The collected data was analysed with SPSS 16.0 version. To 
describe about the data descriptive statistics frequency analysis, 
percentage analysis, mean, S.D were used. To find the significance 
difference between the multiple comparison one way ANOVA with 
Tukey's Post Hoc test was used and to assess the relationship between the 
variables Pearson's Correlation was used.In both the above statistical 
tools the probability value P=.05 is considered as significant level.  
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   Table-3: Comparison of age among study subjects 
Group Variable Age of mother 
Control Mean + SD 24.98 
Range  20-29 
Gestational hypertension 
(GroupI) 
Mean + SD 24.68 
Range  20-29 
Preeclampsia  
Group II) 
Mean + SD 25.09 
Range  20-28 
‘t’ test between  
Group I & Group II 
t value 0.890 
p value 0.377 
‘t’ test between  
Group I & controls 
t value 0.245 
p value 0.807 
‘t’test between  
Group II & controls 
t value 1.054 
p value 0.296 
One way ANOVA F value 0.637 
p value 0.531 
 
Unpaired student’s t test:p>0.05 : Non-significant; 
P<0.01&p<0.05:significant ; p<0.001: Highly significant 
 
 
 Graph-1: Comparison of age among study subjects
The mean  age in controls was
22.30+2.38 years and in Group II it was
significant difference in age among study groups.(p
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 22.13+2.84 years, in Group I it was
 22.83+2.26 years. There was 
-0.531).
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GESTATIONAL AGE 
Table-4:Comparison of period gestation among study subjects 
 
Group Variable Period of Gestation 
Control Mean + SD 37.13 
Range  30-39 
Gestational hypertension 
(GroupI) 
Mean + SD 37.25 
Range  30-40 
Preeclampsia  
Group II) 
Mean + SD 36.25 
Range  30-39 
‘t’ test between  
Group I & Group II 
t value 0.588 
p value 0.559 
‘t’ test between  
Group I & controls 
t value 0.633 
p value 0.529 
‘t’test between  
Group II & controls 
t value 1.380 
p value 0.173 
One way ANOVA F value 0.804 
p value 0.451 
 
Unpaired student’s t test:p>0.05:Non-significant; 
P<0.01&p<0.05:significant;p<0.001:Highly significant 
 Graph-2: Comparison of period of gestation among study subjects
 
The mean period of gestation in controls was
Group I it was 34.33
weeks. There was no significant difference among
(p-0.451) 
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 34.77+2.36
+2.91 weeks and in GroupII it was 
 study groups
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 weeks, in 
33.93+2.32 
  
 Table-5:Comparison of parity among study subjects
 
Control  
GHT 
Preeclampsia  
 
Graph-3 : Comparison of parity among study subjects
 
         In all the groups, 
nulliparous was little higher in cases compared to controls.
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PARITY 
Primi  G2P1L1 G3P2L2
No % No % No 
23 76.7 6 20 1 
24 80 5 16.7 1 
25 83.3 4 13.3 1 
majority were nulliparous. But proportion
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 SOCIO-ECONOMIC STATUS
Table-6:Comparison of socio
 
Control  
GHT 
Preeclampsia  
 
Graph-4:Comparison of socio
There was no significant difference in socio
among study subjects.
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-economic status among study 
 
Class - IV Class 
No % No 
12 40 18 
14 46.7 16 
13 43.3 17 
-economic status among study subjects
-economic status
(p>0.05) 
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% 
60 
53.3 
56.7 
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BMI 
Table-7 : Comparison of BMI among study subjects 
Group Variable BMI 
Control Mean + SD 23.05 
Range  21.09-23.80 
Gestational hypertension 
(GroupI) 
Mean + SD 23.72 
Range  21.09-25.00 
Preeclampsia  
Group II) 
Mean + SD 22.83 
Range  20.70-24.00 
‘t’ test between  
Group I & Group II 
t value 1.210 
p value 0.233 
‘t’ test between  
Group I & controls 
t value 0.228 
p value 0.821 
‘t’test between  
Group II & controls 
t value 1.521 
p value 0.134 
One way ANOVA F value 1.037 
p value 0.359 
 
Unpaired student’s t test:p>0.05:Non-significant; 
P<0.01&p<0.05:significant;p<0.001:Highly significant 
 
 Graph-5:Comparison of BMI among study subjects
The mean BMI of controls was
22.47+1.25 and in Group II it was
difference in BMI among study 
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 22.42+0.63, In Group I it was
 22.16+0.67. There   was no significant 
subjects. (p0.359) 
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SYSTOLIC BLOOD PRESSURE 
Table-8: Comparison of Systolic blood pressure among  
study subjects 
 
Group Variable SBP 
Control Mean + SD 117.010 
Range  100-120 
Gestational hypertension 
(GroupI) 
Mean + SD 161.007 
Range  140-168 
Preeclampsia  
Group II) 
Mean + SD 167.174 
Range  140-170 
‘t’ test between  
Group I & Group II 
t value 2.556 
p value 0.013 
‘t’ test between  
Group I & controls 
t value 21.434 
p value 0.001 
‘t’test between  
Group II & controls 
t value 24.278 
p value 0.001 
One way ANOVA F value 300.137 
p value 0.001 
 
Unpaired student’s t test:p>0.05:Non-significant; 
P<0.01&p<0.05:significant;p<0.001:Highly significant 
 Graph-6: Comparison of systolic blood pressure 
 
 
The mean systolic BP of controls was 112
152+9.007 and in Group II it was 158.33
difference in systolic BP
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among study subjects 
+5.010, In Group I it was 
+9.174. There   was  significant 
 among study subjects.(p-0.001) 
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DIASTOLIC BLOOD PRESSURE 
 
Table-9: Comparison of Diastolic blood pressure  
among study subjects 
 
Group Variable DBP 
Control Mean + SD 102.936 
Range  70-88 
Gestational 
hypertension (GroupI) 
Mean + SD 109.509 
Range  90-114 
Preeclampsia  
Group II) 
Mean + SD 115.604 
Range  90-120 
‘t’ test between  
Group I & Group II 
t value 2.254 
p value 0.028 
‘t’ test between  
Group I & controls 
t value 13.162 
p value 0.001 
‘t’test between  
Group II & controls 
t value 15.598 
p value 0.001 
One way ANOVA F value 126.527 
p value 0.001 
 
  
 Graph-7: Comparison of Diastolic blood pressure 
 
The mean Diastolic BP of controls was 97
101+8.509 and in Group II it was 106.93
difference in diastolic BP
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among study subjects 
 
+5.936, In Group I it was 
+8.674. There   was significant 
 among study subjects(.p-0.001) 
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TRIGLYCERIDES 
 
Table-10:Comparison of triglycerides among study subjects 
Group Variable Triglycerides 
Control Mean + SD 170.03 
Range  91-230 
Gestational hypertension 
(GroupI) 
Mean + SD 199.55 
Range  101-233 
Preeclampsia  
Group II) 
Mean + SD 223.23 
Range  133-259 
‘t’ test between  
Group I & Group II 
t value 2.785 
p value 0.007 
‘t’ test between  
Group I & controls 
t value 3.385 
p value 0.001 
‘t’test between  
Group II & controls 
t value 6.255 
p value 0.001 
One way ANOVA F value 19.17 
p value 0.001 
 
Unpaired student’s t test:p>0.05:Non-significant; 
P<0.01&p<0.05:significant;p<0.001:Highly significant 
 
 Graph-8:Comparison
  
         The mean serum concentrations o
140.37+29.65mg/dl, Group I it is
is 190.67+32.56 mg/dl
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 of triglycerides among study subjects
f triglycerides in controls is 
 167.40+32.15 mg/dl and in Group III it 
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TOTAL CHOLESTEROL 
 
Table-11:Comparison of total cholesterol among study subjects 
Group Variable Total Cholesterol  
Control Mean + SD 188.61 
Range  121-218 
Gestational 
hypertension (GroupI) 
Mean + SD 211.15 
Range  125-259 
Preeclampsia  
Group II) 
Mean + SD 225.30 
Range  166-266 
‘t’ test between  
Group I & Group II 
t value 2.756 
p value 0.008 
‘t’ test between  
Group I & controls 
t value 2.632 
p value 0.011 
‘t’test between  
Group II & controls 
t value 5.937 
p value 0.001 
One way ANOVA F value 15.43 
p value 0.001 
 
Unpaired student’s t test:p>0.05:Non-significant; 
P<0.01&p<0.05:significant;p<0.001:Highly significant 
 
 Graph-9:Comparison of total cholesterol among study subjects
 
The mean serum concentrations of total cholesterol in controls is 
164.90+23.71mg/dl, Group I it was 182.70
it was 201.40+23.90 mg/dl.
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LDL 
 
Table-12:Comparison of LDL among study subjects 
Group Variable LDL 
Control Mean + SD 112.43 
Range  48.4-136.4 
Gestational hypertension 
(GroupI) 
Mean + SD 133.36 
Range  56.2-168.8 
Preeclampsia  
Group II) 
Mean + SD 145.09 
Range  83.4-181.8 
‘t’ test between  
Group I & Group II 
t value 2.162 
p value 0.035 
‘t’ test between  
Group I & controls 
t value 2.518 
p value 0.015 
‘t’test between  
Group II & controls 
t value 5.080 
p value 0.001 
One way ANOVA F value 11.50 
p value 0.001 
 
Unpaired student’s t test:p>0.05:Non-significant; 
P<0.01&p<0.05:significant;p<0.001:Highly significant 
 
 Graph-10:Comparison of LDL among study subjects
 
The mean serum concentrations of  LDL cholesterol in controls is 
91.38+21.05mg/dl, Group I it was 106.92
was 121.03+24.06 mg/dl.
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+26.44 mg/dl and in Group III it 
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HDL 
Table-13:Comparison of HDL among study subjects 
Group Variable HDL 
Control Mean + SD 50.94 
Range  35-58 
Gestational 
hypertension (GroupI) 
Mean + SD 47.41 
Range  30-51 
Preeclampsia  
Group II) 
Mean + SD 46.40 
Range  32-49 
‘t’ test between  
Group I & Group II 
t value 0.055 
p value 0.956 
‘t’ test between  
Group I & controls 
t value 2.378 
p value 0.021 
‘t’test between  
Group II & controls 
t value 2.644 
p value 0.011 
One way ANOVA F value 4.395 
p value 0.015 
 
Unpaired student’s t test:p>0.05:Non-significant; 
P<0.01&p<0.05:significant;p<0.001:Highly significant 
 
 Graph-11:Comparison
 
The mean serum concentrations of HDL cholesterol in controls is 
45.53+5.41mg/dl, Group I it was 42.30
was 42.23+4.17 mg/dl.
The statistical analysis by student’s t
serum levels of triglycerides, total cholesterol and LDL cholesterol are 
significantly increased in subjects with preeclampsia when compared to 
healthy controls (p<0.001) except the mean serum HDL cholesterol level 
which is significantly decreased (p<0.01).
The mean serum levels of triglycerides, total cholesterol and LDL 
cholesterol are significantly increased in subjects with gestational 
hypertension when compared to healthy controls (p<0.01, p<0.05 & 
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p<0.05 respectively) except the mean serum HDL cholesterol level which 
is significantly decreased (p<0.05). 
The mean serum levels of triglycerides, total cholesterol and 
LDL cholesterol are significantly increased in subjects with 
preeclampsia when compared with gestational hypertension subjects. 
(p-0.001, p-0.001, p-0.001 respectively). There was  significant 
decrease in mean serum HDL cholesterol concentration among these 
subjects (p-0.015). 
The statistical analysis by one way ANOVA shows that the mean 
serum levels of triglycerides, total cholesterol and LDL cholesterol are 
significantly increased in subjects with gestational hypertension and 
preeclampsia when compared to healthy controls (p<0.001) except the 
mean serum HDL cholesterol level which is significantly decreased 
(p<0.05). 
CORRELATION OF SEVERITY 
The correlation of serum triglyceride levels with systolic blood 
pressure, serum triglycerides with diastolic blood pressure and serum 
triglyceride with urine albumin is represented in table-14. 
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 There is a highly stastical significant correlation between 
a) Serum triglyceride and systolic blood pressure(r=0.905) 
b) Serum triglyceride and diastolic blood pressure(r=0.969) 
c) Serum triglyceride and urine albumin(r=0.936) 
Table-14:Correlation of serum triglyceride with different parameters 
Parameter ‘r’ value ‘p’value Significance 
Systolic BP 0.905 0.001 HS 
Diastolic BP 0.969 0.001 HS 
Urine albumin 0.936 0.001 HS 
r-Karl Pearson correlation Co-efficient 
HS-Highly significant 
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Graph-13:serum triglyceride with Diastolic blood pressure 
 
 
Graph-14:serum triglyceride with urine albumin 
 
 
99 
 
DISCUSSION 
SERUM LIPID PROFILE: 
SERUM TRIGLYCERIDES: 
The mean serum concentrations of triglycerides in controls is 
140.37+29.65mg/dl,Group I it is 167.40+32.15 mg/dl and in Group III it 
is 190.67+32.56 mg/dl. 
In my study mean serum triglyceride are significantly elevated 
in gestational hypertension and preeclampsia.(p value-0.001) 
           The finding of   the studies done by Q Lei et al
49
, Torun Clausen et 
al
62
, S.WareJauregui et al
50
, Shruthi Mohanty et al
53
 and many other 
researchers coincides with these finding
62,64,65,66,67,68,69,70,71,72,74,75
. 
                There is increase in hepatic lipase activity(by increasing the 
synthesis of TG in liver) and decrease in lipoprotein lipase activity(by 
decreased catabolism of TG at tissue level) are the cause for increased 
triglyceride concentration. There is delay in uptake of remnant by the 
liver leads to rise in TG concentration
64
. 
SERUM TOTAL CHOLESTEROL: 
The mean serum concentration of total cholesterol in controls is 
164.90+23.71 mg/dl; in group I, it is 182.70+28.45mg/dl, and in group II, 
it is201.40+23.90 mg/dl. In my  study it was found that the mean serum 
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levels of total cholesterol are significantly increased in subjects with 
gestational hypertension and preeclampsia when compared to healthy 
controls (p-0.001). 
The finding of   the studies done by,Md.Zakir H et al
65
 
S.WareJauregui et al
50
, Shruthi Mohanty et al
53
 and many other 
researchers coincides with these finding
66,67,69,70,71,74
. 
The increase in cholesterol concentration is due to insulin 
resistance and reverse transport of cholesterol to liver because of reduced 
HDL level. 
 LDL CHOLESTEROL: 
The mean serum concentration of LDL cholesterol in controls is 
91.38+21.05 mg/dl; in group I, it is 106.92+26.44 mg/dl and in group II, 
it is 121.03+24.06 mg/dl. In present study it was found that the mean 
serum levels of LDL cholesterol are significantly increased in subjects 
with gestational hypertension and preeclampsia when compared to 
healthy controls (p-0.001). 
The finding of studies done by  Carlos A. Negrato et al, S.Ware-
Jauregui et al
50
, Q Lei et al49, S. Ware-Jauregui et al50, Torun Clausen et 
al51 and many other researchers.
64,65,66,67,69,70,71,73,74,75 
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HDL CHOLESTEROL: 
The mean serum concentration of HDL cholesterol in controls is 
45.53+5.41 mg/dl; in group I, 4 mg/dl and 42.30+5.11 in group II, it is 
42.23+4.17 mg/dl. In present study it was found that the mean serum 
levels of HDL cholesterol are  significantly decreased in subjects with 
gestational hypertension and preeclampsia when compared to healthy 
controls (p-0.015). 
The studies of Carlos A. Negrato et al, S. Ware-Jauregui et al, 
Q Lei et al and many other researchers are 
correlating.
64,65,66,67,68,69,71,73,74,75
  
Reduction in HDL cholesterol is due to hypertriglyceridemia, 
which forms TG rich HDL particles through CETP mediated exchange 
with TG rich VLDL particles. Hepatic lipase rapidly catabolises TG rich 
HDL particles and decreasing it  concentration. 
A study conducted in primigravida about lipoprotein subfractions  
by 200 subjects divided into 4 groups. There were 50 normotensive 
nonpregnant normal women (group A), 50 normotensive pregnant normal 
women (group B), 50 pregnant women with preeclampsia (group C) and 
50 pregnant women with eclampsia (groupD). Authors found that serum 
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triglyceride, serum VLDL levels were significantly high in preeclamptic 
women when compared with group A and B.  
In the year 2010, Uzma Iftikhar and co-workers found significant 
increase in serum levels of total cholesterol, triglycerides, LDL and 
VLDL and significant decrease in serum levels of HDL in preeclamptic 
women when compared with controls
67
. 
In the same year, Kashinakunti S.V. and co-workers found 
significantly increased fasting serum levels of triglycerides in 
preeclamptic cases when compared with controls. They found positive 
correlation between serum triglycerides and systolic and diastolic blood 
pressure in cases
68
. 
In the same year, Adiga Usha and a co-worker found 
significantly increased  serum levels of total cholesterol and total 
cholesterol:HDL ratio and significantly decreased serum levels of HDL in 
PIH cases when compared with controls. There was significant positive 
correlation between serum total cholesterol and Atherogenic index (AI) 
and significant negative correlation between serum HDL and AI. Total 
cholesterol levels were higher by 25% and HDL levels were lower by 
36% in PIH cases when compared with controls
69
. 
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In the same year, Vidyabati RK and co-workers found 
significantly increased serum levels of total cholesterol, triglycerides, 
LDL and VLDL in PIH cases when compared with controls. For 1 unit 
increase in Total Cholesterol, Triglycerides, VLDL and LDL, there were 
increased chance of developing PIH by 12.6%, 0.3%,12.4% and 7.1% 
respectively. With 1 unit increase in HDL, woman has 11.4% less chance 
of developing PIH
70
. 
In the year 2011, Shalini Maksane and co-workers found 
significantly increased serum levels of total cholesterol, triglycerides, 
LDL, VLDL and significantly decreased serum level of HDL in 
preeclamptic cases when compared with controls
71
. 
In the same year, Valmir Jose de Lima and co-workers 
conducted a case controlstudy with 42 preeclmaptic women as cases and 
35 normal healthy pregnant women as controls at third trimester. Authors 
found significantly elevated serum levels of triglycerides and VLDL in 
cases when compared with controls. They found positive correlation 
between increased proteinuria and higher VLDL and triglyceride levels in 
patients with preeclampsia
72
. 
In the same year, Zinat Begum and co-workers conducted a case-
control study with 75 preeclampsia cases and 75 normal healthy pregnant 
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women as controls.Authors found significantly reduced levels of serum 
HDL in cases when compared with controls.  
In the same year, Gohil JT and co-workers conducted a study 
with 200 women divided into four groups. Group A- 50 nonpregnant 
normotensive women, Group B- 50 healthy pregnant normotensive at 32-
36 weeks of gestation, Group C- 50 antenatal preeclamptic women at 32-
36 weeks of gestation, Group D- 50 post partum preeclamptic women at 
_15 days after delivery. There was significant increase in serum levels of 
total cholesterol, triglycerides, LDL and VLDL and significant decrease 
in serum levels of HDL in group C when compared with group A, B and 
D
74
. 
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SUMMARY 
A total number of 90 subjects were included in this study of which 
30 normal pregnant women were taken as Controls, 30 gestational 
hypertensive women were taken as Group I and 30 preeclamptic women 
were taken as Group II. All subjects were more than 28 weeks of 
gestation with no major illness. 
In all the subjects, concentrations of, serum triglycerides, serum 
total cholesterol and serum HDL cholesterol were estimated. 
The results showed that mean value of serum triglycerides, serum 
total cholesterol, serum LDL cholesterol concentration were significantly 
increased in women with gestational hypertension and preeclampsia when 
compared with healthy pregnant women. The mean serum HDL 
cholesterol concentration was significantly decreased in cases when 
compared with controls. 
This study shows that there is presence of  dyslipidemia in women 
with gestational hypertension and preeclampsia. Dyslipidemia might be 
involved in pathogenesis of these diseases.  
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The women who develop preeclampsia had disturbed lipid 
metabolism. Increased triglyceride levels and delayed triglycerides 
clearance and high blood pressure are reasons for the development of 
preeclampsia. This association may be significant in understanding the 
pathophysiological process of preeclampsia and may help in developing 
strategies for prevention and early diagnosis. 
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CONCLUSION 
 
Due to hormonal changes there is physiological hyperlipidemia 
seen in normal pregnancy. In Preeclampsia triglycerides are elevated 
abnormally beyond the physiological rise of normal pregnancy,so it was 
implicated in pathophysiology of Preeclampsia. Atherogenic lipid profile 
that is raised triglycerides, LDL-C and decreased HDL-C lead to 
development of Preeclampsia by causing oxidative stress and endothelial 
dysfunction. 
Systolic Blood Pressure, Diastolic Blood Pressure and proteinuria 
have positive correlation with triglyceride levels. So, the severity of 
Preeclampsia indicated by serum triglyceride concentration. If 
Preeclampsia diagnosed in present pregnancy the chance of recurrence in 
next pregnancy is high. So, by controlling the risk factors like obesity and 
altered lipid profile the chance of recurrence can be minimized. 
 
This study helps in understanding the role of altered lipid profile in 
the pathophysiology of Preeclampsia. This may lead to development of 
preventive strategies and early diagnosis. By detecting this lipid profile 
changes in early pregnancy, it may be helpful to prevent and to slow 
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down the disease progression either by medication or life style 
modification. 
 
 
  
Factors  influcencing development of preeclampsia in 
dyslipidemia 
• Inhibition of PG synthase causes altered PGI-
2/TXA2-Ratio and impaired endothelial dependent 
relaxation lead to vasospasm. 
• dyslipidemia causes lipid peroxidation leads to  
oxidative stress injury to  cells. 
• Atherosis of spiral arteries in placenta lead to 
triglyceride related vasculopathy and narrowing  of 
vascular lumen leads to placental ischaemia. 
•
Factors  influcencing altered  lipid profile in normal 
pregnancy. 
• Estrogen 
• Insulin Resistance(High in first and second 
trimester. 
•    Hepatic Lipase activity. 
•     Lipoprotein Lipase activity. 
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ANNEXURE-1 
PROFORMA 
 
 
I.Particulars of the Individual: 
   1.Name 
   2.Age 
   3.Sex 
   4.Religion 
   5.Occupation 
   6.Address 
   7.Educational status 
   8.Socio-economic status 
   9.Date of admission 
  10.In patient/Out patient number 
  11.Case-Booked/Unbooked 
 
II.Present History: 
   1.H/O Amenorrhoea 
   2.H/O pedal edema 
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III.Obstetric History: 
    1.Parity index (G-P-L-A) 
    2.Married life 
    3.H/O present pregnancy-1
st
trimester 
                                             2
nd
 trimester 
                                             3
rd
 trimester 
4.H/O previous pregnancy-DM, HT, Epilepsy 
 
 IV.Menstrual History: 
   Last menstrual period(LMP) 
   Expected date of delivery(EDD) 
 
V.Past History: 
    1.H/O Hypertension 
    2.H/O Diabetes Mellitus 
    3.H/O Altered lipid profile 
    4.H/O Drug intake 
    5.H/O Obesity 
 
VI.Family History: 
     1.H/o Diabetes mellitus 
     2.H/o Hypertension 
     3.H/o Preeclampsia in mother or sister 
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VII.Personal History: 
    1.Diet 
    2.Appetite 
    3.Sleep 
    4.Bowel and bladder habits 
    5.H/o smoking 
 
VIII.General Physical Examination: 
   1.Height 
   2.Weight 
   3.Prepregnancy BMI from ante natal records 
   4.Temperature 
   5.Nutrition 
   6.Pallor,Icterus,Clubbing,Cyanosis,Lymphadenopathy,Pedal edema 
   7.Breast,Spine,Thyroid 
 
IX.Vital Data: 
    1.Pulse rate 
    2.Blood pressure 
    3.Respiratory rate 
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X.Systemic Examination: 
  1. Respiratory system 
  2.CVS 
  3.CNS 
  4.Per Abdomen Examination 
        a)Abdominal wall edema 
        b)Uterine size(gestational age)/Fundal height 
        c)Position of Head 
        d)Fetal heart rate and fetal movements 
 
XI.Investigations: 
  1.Hb% 
  2.Blood group 
  3.Blood sugar,urea,creatinine 
  4.Urine albumin 
  5.Liver function test 
  6.Serum uric acid 
  4.Serum lipid profile-Triglycerides,Total cholesterol,LDL,HDL 
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INFORMED CONSENT 
 
I,.................................................. the undersigned agree voluntarily 
to participate in the study , entitled “Study of Serum Lipid Profile in 
Gestational Hypertension and Preeclampsia” I understand that this is 
an invasive procedure wherein the blood investigations will be done. 
The procedure of study  have been explained to me in my own 
language.                                                                                      
 
Date: 
Place : 
                                                                   Signature of the subject 
                                                                   
                                                                      Signature of  investigator 
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MASTER CHART 
Group – II Women with PREECLAMPSIA 
 
S.NO NAME IP NO AGE PARITY GA SES SBP DBP URINEALB HEIGHT WEIGHT BMI S.TG S.TC S.HDL S.LDL 
1 Ruby 31841 21 Primi 34 V 140 90 1+ 152 50 21.64 133 178 41 110.4 
2 Floramary 29978 21 Primi 36 IV 168 118 3+ 156 52 21.36 236 196 49 99.8 
3 Patteswari 28845 23 Primi 36 IV 162 106 2+ 145 48 22.82 184 259 49 173.2 
4 Jancyrani 26894 20 Primi 37 V 160 106 2+ 153 51 21.78 183 189 45 107.4 
5 Rifanabegam 27865 22 Primi 35 V 166 118 3+ 161 54 20.83 229 219 41 132.2 
6 Ruckmani 25674 24 Primi 34 V 160 106 2+ 155 52 21.64 183 187 41 109.4 
7 Sulthana begam 23345 23 Primi 35 V 164 114 3+ 152 50 21.64 216 266 41 181.8 
8 Rahamath nisha 26678 22 Primi 31 IV 168 118 3+ 156 52 21.36 238 190 42 100.4 
9 Bannari 27731 21 Primi 33 IV 162 108 2+ 150 50 22.22 189 187 44 105.2 
10 Umamaheswari 23331 21 Primi 34 IV 160 106 2+ 163 55 20.7 185 221 43 141 
11 hithaya fathima 31199 24 Primi 32 V 170 120 3+ 155 52 21.64 249 192 44 98.2 
12 Sangeetha 29990 25 G2P1L1 36 V 162 106 2+ 155 53 22.06 183 215 44 134.4 
13 Madha 25531 25 Primi 31 V 168 120 3+ 157 51 20.69 230 215 44 125 
14 Gayathri 28881 26 Primi 31 V 140 90 1+ 150 50 22.22 143 220 43 148.4 
15 Jasmin 24415 23 Primi 32 V 152 104 1+ 155 52 21.64 168 166 49 83.4 
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S.NO NAME IP NO AGE PARITY GA SES SBP DBP URINEALB HEIGHT WEIGHT BMI S.TG S.TC S.HDL S.LDL 
16 Thangamani 25891 22 Primi 35 IV 154 104 2+ 153 52 22.21 179 174 38 100.2 
17 Sameemma 30981 21 Primi 36 IV 170 120 3+ 150 50 22.22 259 203 49 102.2 
18 Priya 30897 26 G2P1L1 32 V 166 108 2+ 155 52 21.64 198 192 47 105.4 
19 Sreeja 31674 27 G2P1L1 32 IV 140 90 1+ 153 52 22.21 148 187 40 117.4 
20 Katheeza banu 32189 21 Primi 37 IV 152 104 2+ 150 50 22.22 169 215 47 134.2 
21 Nancy salomin 38765 28 G3P2L2 37 V 162 108 2+ 160 54 21.09 189 207 38 131.2 
22 Annalakshmi 27865 27 G2P1L1 37 V 150 102 1+ 157 53 21.5 163 205 38 134.4 
23 Jumaila 32214 21 Primi 34 IV 168 120 3+ 152 51 22.07 238 184 42 94.4 
24 Vasanthi 31114 20 Primi 32 IV 166 108 2+ 150 51 22.66 198 228 39 149.4 
25 Sakila banu 29810 21 Primi 30 V 160 104 2+ 155 53 22.06 180 184 44 104 
26 Naseema 30021 22 Primi 32 V 146 100 1+ 155 52 21.64 158 178 32 114.4 
27 Gandhimathi 27018 23 Primi 34 IV 154 104 2+ 155 53 22.06 178 195 40 119.4 
28 Mohanapriya 27099 22 Primi 32 V 146 98 1+ 160 54 21.09 156 231 39 160.8 
29 Samsath banu 29055 23 Primi 39 IV 154 104 2+ 155 53 22.06 178 184 36 112.4 
30 Mercy 31964 20 Primi 32 V 160 104 2+ 152 50 21.64 180 175 38 101 
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Group – I Women with Gestational Hypertension 
S.NO NAME IPNO AGE PARITY GA SES SBP DBP URINEALB HEIGHT WEIGHT BMI S.TG S.TC S.HDL S.LDL 
1 Umarani 23453 20 Primi 30 V 140 90 NIL 152 57 24.67 138 172 40 104.4 
2 Thilagavathy 25567 21 Primi 32 IV 154 106 NIL 156 60 24.69 178 172 44 92.4 
3 Sujitha 27899 21 Primi 34 IV 148 98 NIL 145 52 24.76 149 151 47 74.2 
4 Padmapriya 24456 22 Primi 36 V 152 104 NIL 153 57 24.35 167 195 43 118.6 
5 Nithya 21134 20 Primi 34 V 162 112 NIL 161 65 25 192 228 31 158.6 
6 Selvi 23378 25 G2P1L1 32 V 164 114 NIL 152 50 21.64 203 170 48 81.4 
7 Loganayaki 29913 24 Primi 31 IV 162 106 NIL 160 54 21.09 185 188 44 107 
8 Divya 32110 23 Primi 32 IV 140 90 NIL 150 50 22.22 101 153 38 94.8 
9 Rathi 24675 22 Primi 30 IV 148 98 NIL 152 50 21.64 152 246 50 165.6 
10 Rabithbaseera 28895 21 Primi 34 IV 140 90 NIL 160 54 21.09 119 125 45 56.2 
11 Narmadha 23342 21 Primi 36 V 150 106 NIL 155 52 21.64 174 206 46 125.2 
12 Malar 25591 20 Primi 37 IV 160 112 NIL 155 53 22.06 196 154 37 77.8 
13 Kanniyammal 28294 23 Primi 39 V 160 110 NIL 155 53 22.06 193 179 41 99.4 
14 Shakira 23399 24 G2P1L1 38 V 164 114 NIL 150 51 22.66 202 197 30 126.6 
15 Malarvizhi 31312 23 Primi 38 V 162 110 NIL 155 53 22.06 195 176 41 96 
16 vellammal 31112 21 Primi 37 IV 164 112 NIL 152 50 21.64 231 259 44 168.8 
17 Victoria 31162 21 Primi 33 IV 168 114 NIL 150 52 23.11 233 181 40 94.4 
 
 
130 
 
S.NO NAME IPNO AGE PARITY GA SES SBP DBP URINEALB HEIGHT WEIGHT BMI S.TG S.TC S.HDL S.LDL 
18 Bhuvanewari 31716 20 Primi 32 V 162 104 NIL 160 54 21.09 183 176 48 91.4 
19 Radhikamani 31271 20 Primi 34 V 152 104 NIL 159 54 21.35 171 169 45 89.8 
20 Geetharani 29467 21 Primi 33 IV 150 100 NIL 150 52 23.11 166 224 43 147.8 
21 Logu 31322 20 Primi 32 IV 140 90 NIL 150 51 22.66 129 147 42 79.2 
22 Ranjani 30736 23 Primi 31 V 144 94 NIL 155 53 22.06 138 158 42 88.4 
23 Chinnammal 30377 22 Primi 30 V 142 92 NIL 155 53 22.06 134 189 47 115.2 
24 Murugeswari 31064 21 Primi 39 V 150 104 NIL 150 52 23.11 171 185 51 99.8 
25 Pradeepa 31143 27 G2P1L1 40 IV 142 90 NIL 152 50 21.64 133 184 44 113.4 
26 Anusiya 31124 26 G2P1L1 38 IV 160 106 NIL 160 54 21.09 185 183 32 114 
27 Mallika 31177 25 G2P1L1 34 V 146 94 NIL 133 43 24.3 137 172 38 106.6 
28 Maryloosiya 31144 24 Primi 35 V 140 90 NIL 150 51 22.66 131 170 45 98.8 
29 Radhamani 30848 21 Primi 35 V 150 98 NIL 152 50 21.64 158 187 42 113.4 
30 Revathy 31897 29 G3P2L2 34 IV 154 106 NIL 160 54 21.09 178 185 41 108.4 
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Controls – Normal Pregnant Women  
S.NO NAME OP NO AGE PARITY GA SES SBP DBP 
URINE 
ALB 
HEIGHT WEIGHT BMI S.TG S.TC S.HDL S.LDL 
1 Chitra 2500213 24 Primi 32 V 110 70 NIL 152 50 21.64 127 187 46 116 
2 Saharbanu 2411907 20 Primi 34 V 120 80 NIL 150 50 22.22 230 218 46 126 
3 Manimegalai 2567900 25 G2P1L1 34 V 116 76 NIL 145 48 22.82 145 167 48 90 
4 Ranjithadevi 2346567 28 G2P1L1 36 V 110 74 NIL 150 51 22.66 131 171 39 108 
5 Indhu 2476747 21 Primi 39 IV 120 86 NIL 155 53 22.06 182 180 44 99.6 
6 Sathya 2743786 27 G2P1L1 32 IV 116 84 NIL 145 48 22.82 167 163 49 80.6 
7 Subbulakshmi 2577886 21 Primi 34 V 118 86 NIL 155 53 22.06 171 154 47 72.8 
8 Kasthuri 2388787 20 Primi 30 IV 110 80 NIL 155 52 22.21 148 121 43 48.4 
9 Jothi 2778678 22 Primi 36 V 120 88 NIL 153 52 22.21 180 213 47 130 
10 Fathima 2177876 21 Primi 36 V 110 80 NIL 155 52 22.06 152 134 53 50.6 
11 Kalpana 2278687 20 Primi 37 V 110 70 NIL 150 50 22.22 119 162 48 90.2 
12 Ramya 2447689 20 Primi 36 IV 110 70 NIL 145 48 22.82 131 159 42 90.8 
13 Jeya 2337896 20 Primi 38 V 120 86 NIL 150 51 22.66 170 178 52 92 
14 Vidhya 2679854 20 Primi 38 V 110 70 NIL 150 51 22.66 91 124 40 65.8 
15 Veni 2877986 21 Primi 32 V 110 78 NIL 145 48 22.82 135 184 47 110 
16 Bharathi 2668945 20 Primi 33 IV 110 70 NIL 155 53 22.06 97 130 38 72.6 
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S.NO NAME OP NO AGE PARITY GA SES SBP DBP 
URINE 
ALB 
HEIGHT WEIGHT BMI S.TG S.TC S.HDL S.LDL 
17 Tamilponni 2453189 20 Primi 37 V 110 78 NIL 150 52 23.11 138 178 47 103.4 
18 Nagalakshmi 2998766 26 G2P1L1 37 V 110 80 NIL 150 51 22.66 141 171 37 105.8 
19 Pavithra 2987654 23 Primi 39 IV 110 74 NIL 145 48 22.82 106 156 42 92.8 
20 Sridevi 2778994 25 G2P1L1 35 IV 114 76 NIL 160 54 21.09 129 167 42 99.2 
21 Shanthi  2113445 20 Primi 36 V 100 70 NIL 151 51 22.36 114 149 52 74.2 
22 Angel 2889576 20 Primi 33 IV 114 70 NIL 150 52 23.11 116 159 35 100.8 
23 Nirmala 2897564 23 Primi 34 V 110 74 NIL 155 53 22.06 124 145 42 78.2 
24 Kavitha 2747868 24 Primi 35 V 110 76 NIL 145 50 23.8 129 158 49 83.2 
25 Marumalar selvi 2786235 29 G3P2L2 34 V 114 80 NIL 150 53 23.5 140 163 39 96 
26 Ambika 2995234 25 G2P1L1 33 IV 118 86 NIL 150 51 22.66 173 215 44 136.4 
27 Beena 2333678 22 Primi 31 IV 110 80 NIL 159 54 21.35 160 169 54 83 
28 Sudha 2666678 21 Primi 32 IV 110 70 NIL 155 53 22.06 124 154 58 71.2 
29 Masilamani 2999967 20 Primi 34 IV 110 78 NIL 160 54 21.09 140 149 46 75 
30 Shantha 3266456 20 Primi 36 V 100 70 NIL 145 48 22.82 101 169 50 98.8 
 
ABSTRACT 
Background: 
           Gestational hypertension and preeclampsia are classified as hypertensive 
disorders of pregnancy. They are one of the major causes for increased 
mortality and  morbidity in mother and fetus. In these disorders, Placental 
ischemia and inflammation occur due to impaired trophoblastic invasion into 
uterine spiral artery. Inflammatory mediators released from ischemic placenta 
into the circulation lead to insulin resistance and dyslipidemia which further 
lead to endothelial dysfunction and hypertension. 
Keywords: Dyslipidemia; gestational hypertension; preeclampsia. 
AIMS 
1.To compare the serum lipid parameters(triglycerides,total 
cholesterol,LDL,HDL) of normal pregnant women with gestational 
hypertension and preeclampsia. 
OBJECTIVES 
1. To measure serum lipid profile in gestational hypertension,preeclampsia 
and normal pregnant women. 
2.  To compare serum lipid profile levels in three groups. 
    3.To  know the role of altered lipid profile in the  pathophysiology of        
preeclampsia. 
   4.To establish the relationship between serum lipid profile and preeclampsia 
   5.To  correlate  the  lipid  profile   levels  with the severity of preeclampsia. 
 
Methods: 
     Case control study was done taking 30 women with gestational hypertension 
as Group-I, 30 women with preeclampsia as Group-II and 30 age matched 
healthy pregnant women as controls. 
     In all the subjects, concentrations of  serum triglycerides, total cholesterol 
and HDL were estimated using enzymatic methods in semiautoanalyser. LDL 
calculated by Friedwald's formula using triglyceride,total cholesterol,HDL 
values.  
Results: 
     The mean concentrations of triglyceride,total cholesterol,LDL were 
significantly increased and HDL concentration significantly decreased  in 
women with hypertensive disorders of pregnancy when compared with healthy 
pregnant women. Systolic blood pressure , diastolic blood pressure and urine 
albumin have positive correlation with triglyceride concentration. 
Interpretation and conclusion: 
              This study suggests that  dyslipidemia is present in women 
with gestational hypertension and preeclampsia. The serum lipid profile in these 
conditions may help to detect the disease progression.It leads to development 
strategies to prevent recurrence in next pregnancy by life style modification and 
medication.As Systolic blood pressure,Diastolic blood pressure and urine 
albumin have positive correlation with triglyceride concentration it indicates the 
severity of disease. 
 
 
